Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BOTULINUM TOXIN TYPE A Cause Back injury? 360 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 360 reports of Back injury have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 9.6% of all adverse event reports for BOTULINUM TOXIN TYPE A.

360
Reports of Back injury with BOTULINUM TOXIN TYPE A
9.6%
of all BOTULINUM TOXIN TYPE A reports
360
Deaths
285
Hospitalizations

How Dangerous Is Back injury From BOTULINUM TOXIN TYPE A?

Of the 360 reports, 360 (100.0%) resulted in death, 285 (79.2%) required hospitalization, and 287 (79.7%) were considered life-threatening.

Is Back injury Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 360 reports have been filed with the FAERS database.

What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?

Off label use (1,785) Drug ineffective (1,175) Drug intolerance (1,004) Product use in unapproved indication (950) Headache (797) Migraine (775) Maternal exposure during pregnancy (716) Pain (714) Hypoaesthesia (703) Nausea (665)

What Other Drugs Cause Back injury?

ADALIMUMAB (1,097) METHOTREXATE (824) RITUXIMAB (778) LEFLUNOMIDE (759) TRAMADOL (673) SECUKINUMAB (670) ABATACEPT (659) OXYCODONE (653) TOCILIZUMAB (645) HYDROXYCHLOROQUINE (637)

Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Back injury Risk?

BOTULINUM TOXIN TYPE A vs BREMELANOTIDE BOTULINUM TOXIN TYPE A vs BRENTUXIMAB BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN BOTULINUM TOXIN TYPE A vs BREO ELLIPTA BOTULINUM TOXIN TYPE A vs BREXANOLONE

Related Pages

BOTULINUM TOXIN TYPE A Full Profile All Back injury Reports All Drugs Causing Back injury BOTULINUM TOXIN TYPE A Demographics